A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies

Abroad (travel likely)Recruiting

Conditions

Friedreich Ataxia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Evidera, Morrisville, North Carolina, United States
Study coordinator · 919-270-6678
Contact: Principal Investigator (Ronna Chan)

Study leads

Medical Director
Study Director
Biogen

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

Friedreich Ataxia

Abroad (travel likely)RecruitingPHASE3

Los Angeles, United States · Gainesville, United States

Efficacy of Omaveloxolone Treatment for Dysphagia in French Patients With Friedreich's Ataxia

Friedreich Ataxia

Abroad (travel likely)Recruiting

Nice, France

A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

Friedreich Ataxia

Abroad (travel likely)Recruiting

Los Angeles, United States · Aurora, United States

Clinical Course Of Disease In Participants With FA-CM

Friedreich Ataxia · Cardiomyopathy

Abroad (travel likely)Recruiting

La Jolla, United States · Tampa, United States